Stocklytics Platform
Asset logo for symbol TECH
Bio-Techne
TECH49
$50.17arrow_drop_up2.26%$1.10
S&P500
Asset logo for symbol TECH
TECH49

$50.17

arrow_drop_up2.26%
Key Stats
Open$51.31
Prev. Close$49.08
EPS0.98
Next Earnings DateJun 6, 2025
LOWHIGH
Day Range49.08
53.38
52 Week Range46.01
85.57
Ratios
EPS0.98
Fundamentals
Industry average yield2.87%
Last Dividend pay dateFeb 28, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

TECH-
US Healthcare Sector-
US Market-
check_circle

TECH / Market

TECH exceeded the US Market which returned 1.34% over the last twenty four hours.
warning

TECH / Healthcare Sector

TECH lose to the US Healthcare sector which returned 3.57% over the last twenty four hours.

Bio-Techne (TECH) Statistics

Bio-Techne Corp (TECH) is a leading provider of life science tools and diagnostics solutions. With a strong focus on innovation and customer satisfaction, the company has become a trusted partner for researchers and clinicians worldwide.
When it comes to statistics, Bio-Techne Corp stands out with its impressive performance. The stock has shown consistent growth over the years, outperforming the sector average. Its valuation metrics are also favorable, indicating that the stock is priced reasonably compared to its peers.
add Bio-Techne to watchlist

Keep an eye on Bio-Techne

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Bio-Techne (TECH) stock's performance compared to its sector and the market over the past year?

Over the past year, Bio-Techne (TECH) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.19%, Bio-Techne has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 37.34%, it has fallen short of the market average. This comparison highlights Bio-Techne's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Bio-Techne (TECH) stock?

The PE (Price to Earnings) ratio of Bio-Techne (TECH) is currently 51.19. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Bio-Techne (TECH) stock?

The Earnings Per Share (EPS) for Bio-Techne (TECH), calculated on a diluted basis, is $0.98. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Bio-Techne (TECH) stock?

The operating margin for Bio-Techne (TECH) is 17.76%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Bio-Techne (TECH) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Bio-Techne (TECH) is $345.78M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Bio-Techne (TECH) have?

Bio-Techne (TECH) has a total debt of $395.13M. The net debt, which accounts for cash and cash equivalents against the total debt, is $217.58M.

Take Your Investments to a Whole New Level